(Q74463873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Predictors of adverse outcome in cancer patients with candidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

E J Anaissie

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

O Uzun

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Vartivarian

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

238-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

Risk factors for hospital-acquired candidemia. A matched case-control study

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Hospital-acquired fungemia. Its natural course and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Fungemia in patients with leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Bacteremia and fungemia in patients with neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Fungemia with compromised host resistance. A study of 70 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

A simplified acute physiology score for ICU patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

The pathogenesis of sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Fungal infections complicating acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

The epidemiology of hematogenous candidiasis caused by different Candida species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900030-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00030-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9552086%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference